85 related articles for article (PubMed ID: 3621214)
1. Phase II trial of oral methotrexate and dipyridamole in colorectal carcinoma.
Wadler S; Subar M; Green MD; Wiernik PH; Muggia FM
Cancer Treat Rep; 1987 Sep; 71(9):821-4. PubMed ID: 3621214
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of sequential methotrexate-5-FU therapy in advanced measurable colorectal cancer.
Cantrell JE; Brunet R; Lagarde C; Schein PS; Smith FP
Cancer Treat Rep; 1982 Jul; 66(7):1563-5. PubMed ID: 7093972
[TBL] [Abstract][Full Text] [Related]
3. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Tixi LM; Bolli EA; Rosso R; Mammoliti S; Rollandi GA; Bertoglio S
Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066
[TBL] [Abstract][Full Text] [Related]
4. Sequential methotrexate and 5-FU in the treatment of colorectal cancer.
Weinerman B; Schacter B; Schipper H; Bowman D; Levitt M
Cancer Treat Rep; 1982 Jul; 66(7):1553-5. PubMed ID: 6980048
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of mitomycin C, cyclophosphamide, and methotrexate in drug-resistant colorectal carcinoma.
Presant CA; Ratkin G; Klahr C
Cancer Treat Rep; 1978 Apr; 62(4):549-50. PubMed ID: 350389
[No Abstract] [Full Text] [Related]
6. [A new sequential chemotherapy of methotrexate with 5-fluorouracil against advanced colo-rectal cancer].
Fujiki T; Futatsuki K; Akazawa S; Yamamoto K; Miyazaki M; Kanda Y; Amemiya K; Uchida N; Oishi T
Gan To Kagaku Ryoho; 1993 Apr; 20(5):603-9. PubMed ID: 8470917
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of sequential methotrexate and 5-FU plus mitomycin and leucovorin in patients with disseminated large bowel cancer: a Northern California Oncology Group study.
Ignoffo RJ; Friedman MA; Gribble M; Hannigan J; Reynolds R; Yu KP; Schiff S; Congdon JE
Cancer Treat Rep; 1984; 68(7-8):983-8. PubMed ID: 6611204
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
[TBL] [Abstract][Full Text] [Related]
9. Sequential methotrexate plus 5-FU in advanced breast and colorectal cancers: a phase II study.
Kaye SB; Sangster G; Hutcheon A; Habeshaw T; Crossling F; Ferguson C; McArdle C; Smith D; George WD; Calman KC
Cancer Treat Rep; 1984 Mar; 68(3):547-8. PubMed ID: 6704984
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial: mitomycin c and methotrexate combination therapy for advanced colorectal carcinoma.
Budman DR; Schulman P; Vinciguerra V; Degnan T
Cancer Treat Rep; 1981; 65(5-6):535. PubMed ID: 7237477
[No Abstract] [Full Text] [Related]
11. Phase I study of UFT plus leucovorin in advanced colorectal cancer: a double modulation proposal.
González Barón M; Feliu J; Ordoñez A; Colmenarejo A; Espinosa E; Zamora P; de la Gandara I; Jalon JI
Anticancer Res; 1993; 13(3):759-62. PubMed ID: 8317909
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
[TBL] [Abstract][Full Text] [Related]
13. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
[TBL] [Abstract][Full Text] [Related]
14. Double modulation with methotrexate and L-leucovorin of weekly 24- hour fluorouracil infusion in fluorouracil-refractory colorectal cancer.
Colleoni M; Nelli P; Vicario G; Pancheri F; Sgarbossa G; Manente P
Anticancer Res; 1996; 16(5B):3101-4. PubMed ID: 8920775
[TBL] [Abstract][Full Text] [Related]
15. Use of high-dose oral methotrexate sequenced at 24 hours with 5-FU: a clinical toxicity study.
Benz C; Silverberg M; Cadman E
Cancer Treat Rep; 1983 Mar; 67(3):297-9. PubMed ID: 6831477
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
Edelman MJ; Meyers FJ; Houston J; Lauder I
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of 5-fluorouracil plus melphalan in colorectal carcinoma.
Presant CA; Ratkin G; Klahr C
Cancer Treat Rep; 1978 Mar; 62(3):461-2. PubMed ID: 348317
[No Abstract] [Full Text] [Related]
18. 5-FU, methotrexate, and mitomycin in advanced colorectal adenocarcinoma: a phase II study.
Biran H; Sulkes A; Biran S
Cancer Treat Rep; 1981; 65(9-10):924-5. PubMed ID: 7273031
[No Abstract] [Full Text] [Related]
19. Double modulation of 5-fluorouracil by leucovorin and low-dose methotrexate in advanced colorectal cancer.
Stabuc B; Markovic A; Plesnicar A; Cizej TE
Neoplasma; 2000; 47(4):248-52. PubMed ID: 11043831
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of iv 6-thioguanine in advanced colorectal carcinoma.
Britell JC; Moertel CG; Kvols LK; O'Connell MJ; Rubin J; Schutt AJ
Cancer Treat Rep; 1981; 65(9-10):909-10. PubMed ID: 7273027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]